Find policies, billing codes, payers, states, and providers
CPT 4011F: Prescription of Antiplatelet Therapy to Prevent Thrombosis
CPT code 4011F documents when a clinician prescribes an antiplatelet medication to prevent platelets from aggregating and thereby reduce the risk of myocardial infarction and ischemic stroke. Nationally, capturing this clinical action with a discrete code supports quality measurement, care coordination, and population-level tracking of secondary prevention strategies for cardiovascular disease. Common settings for this service include outpatient primary care and cardiology clinics where ongoing medication management and follow-up occur.
Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a compact briefing on the clinical intent of the code, the service context, and what to expect from payer coverage patterns and quality measurement use. The publication outlines standard benchmarks and reporting uses where available, summarizes relevant policy considerations affecting documentation and billing for antiplatelet therapy prescriptions, and provides clinical context about the role of antiplatelet agents in preventing thrombotic events. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 4011F policy alerts
Get alerted when payer policies referencing 4011F are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 4011F indicates that the provider prescribes a drug that prevents platelets from sticking together, reducing the risk of heart attack and stroke. This service represents prescription management of antiplatelet therapy aimed at preventing thrombotic cardiovascular events.
-
Service type: Prescription medication management for antiplatelet therapy
-
Typical site of service: Outpatient clinic, primary care office, cardiology clinic, or other ambulatory care settings where medication management and follow-up occur